.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 6,051,259

« Back to Dashboard

Claims for Patent: 6,051,259

Title: Composition for sustained release of human growth hormone
Abstract:The method of the invention for producing a composition for the sustained release of biologically active hGH includes dissolving a biocompatible polymer in a polymer solvent to form a polymer solution, dispersing particles of biologically active, metal cation-stabilized hGH in the polymer solution, and then solidifying the polymer to form a polymeric matrix containing a dispersion of said hGH particles.
Inventor(s): Johnson; OluFunmi Lily (Cambridge, MA), Ganmukhi; Medha M. (Carlisle, MA), Bernstein; Howard (Cambridge, MA), Auer; Henry (Chicago, IL), Khan; M. Amin (Downington, PA)
Assignee: Alkermes Controlled Therapeutics, Inc. (Cambridge, MA)
Application Number:09/252,746
Patent Claims: 1. A composition for the sustained release of human growth hormone from a polymer matrix comprising:

a) poly(lactide-co-glycolide); and

b) particles of zinc-complexed human growth hormone, with a zinc cation component-to-human growth hormone molar ratio between about 4:1 and about 100:1, wherein said particles are dispersed within the poly(lactide-co-glycolide) and wherein the proportion of human growth hormone in the sustained release composition is between 10 and 30 weight percent.

2. The composition of claim 1 wherein the zinc cation component-to-human growth hormone molar ratio is about 10:1.

3. The composition of claim 2 further comprising a second metal cation component, wherein the second metal cation component is not complexed to said human growth hormone, and wherein the second metal cation component is dispersed within the polymer matrix at a concentration of at least about 1% by weight of polymer.

4. The composition of claim 1 wherein the poly(lactide-co-glycolide) has a lactide: glycolide ratio of 1:1.

5. The composition of claim 4 wherein the poly(lactide-co-glycolide) is unblocked.

6. The composition of claim 5 wherein the molecular weight of the poly(lactide-co-glycolide) is about 6,000 to about 31,000 Daltons.

7. A method of delivering human growth hormone to a subject in need thereof comprising the step of administering to said subject a composition for the sustained release of human growth hormone comprising:

a) poly(lactide-co-glycolide); and

b) particles of zinc-complexed human growth hormone, with a zinc cation component-to-human growth hormone molar ratio between about 4:1 and about 100:1, wherein said particles are dispersed within the poly(lactide-co-glycolide) and wherein the proportion of human growth hormone in the sustained release composition is between 10 and 30 weight percent.

8. The method of claim 7 wherein the zinc cation component-to-human growth hormone molar ratio is about 10:1.

9. The method of claim 8 further comprising a second metal cation component, wherein the second metal cation component is not complexed to said human growth hormone, and wherein the second metal cation component is dispersed within the polymer matrix at a concentration of at least about 1% by weight of polymer.

10. The method of claim 7 wherein the poly(lactide-co-glycolide) has a lactide: glycolide ratio of 1:1.

11. The method of claim 10 wherein the poly(lactide-co-glycolide) is unblocked.

12. The method of claim 11 wherein the molecular weight is about 6,000 to about 31,000 Daltons.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc